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Abstract We previously found a brain-specific glycoprotein in
the rat brain. It postnatally increases and is rich in the mature
brain. We cloned cDNA of this protein. It is composed of a signal
peptide, a V-type immunoglobulin domain, two C1-type im-
munoglobulin domains, a transmembrane segment and a
cytoplasmic region containing two tyrosine-based activation
motifs (TAM) that are variants of the antigen receptor signaling
motifs. The overall structure is similar to those of immune
antigen receptors. This molecule, BIT (brain immunoglobulin-
like molecule with TAMs), is a major endogenous substrates of
brain tyrosine kinases in vitro. Cerebral cortical neurons could
extend their neurites on BIT-coated substrate and anti-BIT
monoclonal antibody specifically inhibited the effect. These
findings and our recent study concerning BIT signal transduction
mechanism suggest that BIT, an immune antigen receptor-like
molecule of the brain, functions as a membrane signaling
molecule that may participate in cell^cell interaction.
z 1997 Federation of European Biochemical Societies.
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1. Introduction
Many immunoglobulin superfamily molecules have been
found in the nervous system as in the immune system. They
are generally divided into two groups. The ¢rst group consists
of adhesion molecules such as neural cell adhesion molecule
(NCAM) and L1, and the second group consists of growth
factor receptors such as platelet-derived growth factor recep-
tor and ¢broblast growth factor receptor. The immune system
has another group, antigen recognition molecules, which con-
sists of immunoglobulins, T-cell receptors (TCR) and major
histocompatibility complex (MHC) molecules, and this group
possesses C1-type immunoglobulin domains. Neural mole-
cules that show a high degree of structural homology to these
immune molecules have not been reported. The antigen rec-
ognition molecules appear to have evolved quite recently
through vertebrate evolution in comparison with other immu-
noglobulin superfamily molecules [1]. Then, they have become
to bear the most specialized functions in the mammalian im-
mune system. Thus, if a molecule that has structural homol-
ogy to the antigen recognition molecules is present in the
brain, it will be very interesting to determine what role it plays
in the mammalian brain.
We previously found a brain-speci¢c glycoprotein in the rat
brain using monoclonal antibody 1D4 [2,3]. This glycoprotein
postnatally increased and was highly expressed in the mature
brain [2]. The time course of the protein increase appears to
be related to that of synaptogenesis in the brain. In the
present study, we cloned the cDNA encoding this protein.
The deduced amino acid sequence shows that it is composed
of a signal peptide, a V-type immunoglobulin domain, two
C1-type immunoglobulin domains, a transmembrane segment
and a cytoplasmic region containing two tyrosine-based acti-
vation motifs (TAM) that are variants of antigen receptor
signaling motifs. The overall structure is similar to those of
the immune antigen receptors. This molecule is named BIT
(brain immunoglobulin-like molecule with tyrosine-based acti-
vation motifs). Each immunoglobulin domain of BIT shows
high degrees of homology to immunoglobulin domains of
immunoglobulins, TCRs and MHC molecules. Moreover,
BIT contains two longer variants of typical TAM, which
has been characterized as a signaling motif of T- and B-cell
receptors [4^7]. Furthermore, each cytoplasmic TAM of BIT
contains two sequences homologous to those of insulin recep-
tor substrate-1 (IRS-1), which interact with SHP-2 protein
tyrosine phosphatase. Our recent study concerning signal
transduction of BIT showed that BIT actually interacts with
SHP-2 [8].
In the present study, we demonstrated that BIT is one of
major endogenous substrates of brain tyrosine kinases in vi-
tro, indicating that BIT is a quite important molecule in signal
transduction in the brain. Furthermore, we showed that cul-
tured cerebral cortical neurons could extend their neurites on
BIT-coated plate. Anti-BIT monoclonal antibody 1D4, which
recognizes the extracellular part of BIT, speci¢cally inhibited
the neurite extension on BIT, but it did not on laminin. These
¢ndings demonstrate that an immune antigen receptor-like
molecule exists in the brain, and suggest that the molecule,
BIT, functions as a membrane signaling molecule that may
participates in cell^cell interaction.
2. Materials and methods
2.1. Cloning of BIT cDNA
Puri¢ed BIT [3] was digested with lysyl-endopeptidase and the pep-
tide isolated by HPLC was microsequenced. The N-terminal sequence
of the puri¢ed BIT was also analyzed. Speci¢c antibodies for BIT
were isolated from rabbit anti-BIT serum [2] using a column prepared
with CNBr-activated Sepharose 4B and puri¢ed BIT. The antibodies
were used to screen a rat brain cDNA library in Vgt11 (RL1043a,
Clontech). A clone was obtained and its insert was used for further
screening of a rat brain cDNA library in Vgt10 (RL1025b, Clontech).
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Some positive clones were obtained. After subcloning the inserts into
the Bluescript II KS
ÿ
plasmid (Stratagene), the nucleotide sequences
of the cDNA inserts were determined by dideoxy chain termination in
both directions. Overlapping sequences of the cDNA clones gave a
single open reading frame and included two amino acid sequences
obtained by peptide microsequencing.
2.2. Northern blot analysis
Total RNAs (5.4 Wg) from rat several tissues were resolved by
electrophoresis through 1% agarose formaldehyde gel, transferred to
Hybond N (Amersham) and hybridized with the 1.7-kb BIT cDNA
insert of pRB10.7. Hybridization proceeded at 65³C using rapid hy-
bridization bu¡er (Amersham). The blots were washed at room tem-
perature with 2USSC and 0.1% SDS, then at 65³C with 0.1USSC and
0.1% SDS.
2.3. Immunoblot analysis of BIT expression
Rat tissues were homogenized in 20 mM Tris-HCl (pH 6.8) con-
taining 2% SDS and 2% 2-mercaptoethanol, and the homogenates (10
Wg protein) were resolved on a 10% SDS-polyacrylamide gel, trans-
ferred onto a PVDF membrane (Millipore), and immunoblotted with
anti-BIT serum [2]. Detection proceeded using peroxidase^antiper-
oxidase complex as described previously [3] except that peroxidase
activity was detected in the presence of 5 mg/ml of
(NH
4
)
2
Ni(SO
4
)
2
W6H
2
O for high sensitivity.
2.4. Tyrosine phosphorylation of BIT in vitro
Rat brain homogenate (8%) in solution A containing 15 mM
HEPES-Tris (pH 7.5), 1 mM Na
3
VO
4
, 1 Wg/ml leupeptin, 1 Wg/ml
antipain, 0.7 Wg/ml pepstatin, 0.1 mM PMSF and 200 Wg/ml 1,10-
phenanthroline monohydrate was centrifuged at 1000Ug for 10
min. The supernatant diluted with the same volume of solution A
was incubated with or without 10 mM ATP in the presence of
5 mM MgCl
2
and 5 mM MnCl
2
at 30³C for 10 min. The reaction
was stopped with the same volume of NEHPF solution containing
150 mM NaCl, 5 mM EDTA, 15 mM HEPES-Tris, 100 mM sodium
phosphate (pH 7.4) and 50 mM NaF. Proteins were solubilized with
1% CHAPS at 4³C. The solubilized CHAPS lysates (1 ml) were mixed
with 30 Wl of monoclonal antibody 1D4^Sepharose suspension at 4³C
overnight. The CHAPS lysates, the unadsorbed supernatants and the
washed immunoprecipitates were immunoblotted as described above
with monoclonal anti-phosphotyrosine (4G10) antibody (UBI) and
monoclonal anti-BIT (1D4) antibody [2].
2.5. Cerebral cortical cell culture
96-well plates were coated with nitrocellulose as described [9]. Bo-
vine serum albumin (BSA) (10 mg/ml), poly-L-lysine, (0.1 mg/ml),
laminin (Collaborative Research) (0.4 mg/ml), or puri¢ed BIT (0.15
mg/ml) were applied to the wells. After 10 min, the solutions were
removed and free nitrocellulose was blocked by washing with culture
medium (Eagle's minimum essential medium (MEM) with 19.4 mM
glucose, 6 mM NaHCO
3
, 60 nM Na
2
SeO
3
, 84 Wg/ml gentamicin sul-
fate and 10% fetal bovine serum). Cerebral cortex cells were prepared
from embryonic day 17 rat embryos as described [10] and added to
each well at a concentration of 1U10
5
cells/well. The cells were main-
tained in the culture medium at 37³C in 5% CO
2
. After 45 h incuba-
tion, cultures were ¢xed with 4% paraformaldehyde in PBS. For anti-
body inhibition test, prior to addition of cells, 0.1 mg/ml monoclonal
anti-BIT antibody (1D4) or control monoclonal antibody (3B12a)
in PBS were added into the wells and allowed to incubate for 1 h.
The wells were then washed with the culture medium and cells were
added as described. After 24 h incubation, cultures were ¢xed as
described.
3. Results
3.1. Cloning of BIT cDNA
To clone cDNA of this molecule, initially we screened a rat
brain cDNA library in Vgt11 using the speci¢c polyclonal
antibody, and then an insert from a positive clone was used
for further screening of a rat brain cDNA library in Vgt10.
Some positive clones were obtained and overlapping cDNA
clones gave a single open reading frame. It included two ami-
no acid sequences obtained by peptide microsequencing (Fig.
1A). This molecule, BIT, is composed of a signal sequence, a
V-type immunoglobulin domain, two C1-type immunoglobu-
lin domains, a transmembrane segment and a cytoplasmic
region containing two TAMs. The overall structure is similar
to those of immune antigen receptors (Fig. 1B). We illustrate
BIT as a monomer and as a dimer. The possibility of BIT
dimer formation is supported by the facts that a part of
puri¢ed BIT sometimes migrates at the dimer position in
SDS-PAGE even after boiling in the presence of 1% 2-mer-
captoethanol, and that the putative BIT dimer is detected by
immunoblotting after incubation of the brain membrane frac-
tion with chemical cross-linker. Mature BIT without a signal
peptide is composed of 478 amino acids and has a calculated
molecular weight of 52 714. Rat brain BIT is highly glycosy-
lated and its molecular weight is about 90 kDa [3]. This is
consistent with the ¢nding that the extracellular structure of
BIT has ¢fteen putative N-glycosylation sites.
3.2. Properties of immunoglobulin-like domains of BIT
The ¢rst immunoglobulin-like domain has characteristics of
the V-type [11], which is larger than C1 and C2-types and has
the unique consensus amino acids, as shown in Fig. 2A. The
V-type sequence shows a high degree of homology to those of
the TCRK and -N chains and immunoglobulin light chains
(Table 1). Judging from the size and the consensus amino
acids, the two immunoglobulin-like domains are of the C1-
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Fig. 1. Structure of BIT. A: Nucleotide sequence and amino acid sequence of BIT. N-terminal amino acid sequences of puri¢ed BIT and of a
peptide obtained by lysyl-endopeptidase digestion are indicated by dotted lines. A putative signal sequence and a hydrophobic transmembrane
region are underlined. Possible N-glycosylation sites (Asn^X^Ser/Thr) are indicated by open triangles. Cysteines likely to form disul¢de bonds
in the three immunoglobulin-like domains are circled. Putative phosphorylation sites for protein kinase C and casein kinase II are indicated by
open circles and open squares, respectively. The tyrosine residues of two TAMs are indicated by closed circles. B: Structural similarity between
BIT, T-cell receptor (TCR) and B-cell receptor (BCR). BIT is illustrated as a monomer and as a dimer.
Table 1
Immunoglobulin-like domains homologous to those of BIT
BIT domain Homologous domain Residue identity
V-like domain TCR VN sheep 32%
(32^147) TCR VK human 31%
Ig VU human 31%
Ig VV human 31%
C1-like domain Ig CU pig 35%
(152^249) Ig CH4 horned shark 31%
IgG3 CH1 mouse 31%
MHC II L wild mouse 31%
C1-like domain IgG4 CH3 human 30%
(254^352) Ig CH4 lady¢sh 29%
IgG1 CH3 human 29%
IgG3 CH3 mouse 28%
The search was performed using the IG-Suite FastDB. Analyzed se-
quences of BIT are indicated by amino acid positions in parentheses.
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Fig. 2. Alignment of BIT with homologous sequences. Gaps are indicated by 3. r, rat; m, mouse; h, human. Alignment of the ¢rst immuno-
globulin-like domain (51^126) of BIT with V domains (A) and the second (168^233) and third (270^336) immunoglobulin-like domains with C1
domains (B). All the sequences shown here were taken from Williams and Barclay [11]. The characteristic residues for each domain are indi-
cated by asterisks. Four or more identical residues are shaded. C: Alignment of the J-like sequence (136^147) of BIT with those of other mole-
cules. The numbers of residues identical with BIT are indicated. The sequences of hIg V (Wah), hCD7, rMRC Ox-2 and all others are taken
from [26], [13], [14] and [12], respectively. The J-region sequence of mouse V chain corresponds to the consensus sequence given in ref.[12]. D:
Alignment of the N-TAM (424^463) and C-TAM (464^504) of BIT with those of other molecules. Consensus residues are indicated at the top
and are shaded in the sequences. The sequences shown here are taken from [5], [16] and [17]. E: Alignment of the cytoplasmic sequences of
BIT with the sequences of human IRS-1. The alignments were obtained by BLAST search. Conservative amino acids are indicated by +.
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type [11] (Fig. 2B), which have been found only in molecules
involved in antigen recognition. The ¢rst C1-type domain
shows a high degree of homology to the C1 domains of the
immunoglobulins and MHC molecules (Table 1). The second
C1-type domain shows a high degree of homology to the C-
terminal C1 domains of immunoglobulins and MHC mole-
cules (Table 1), and has a consensus sequence pattern (Phe/
Tyr^X^Cys^Val/Ala^X^His) found in the C-terminal C1 do-
mains of immunoglobulins and MHC molecules. Moreover,
BIT has a sequence homologous to the J sequences of immu-
noglobulins and TCRs (Fig. 2C). J-like sequences were also
found in CD8 L [14], CD7 [15] and MRC Ox-2 [16], but that
of BIT has more amino acids identical to those of immuno-
globulins and TCRs. Thus, the extracellular part of BIT is
highly homologous to those of the immune antigen receptors.
3.3. Properties of BIT-TAM
The cytoplasmic region includes two variants of TAM (Fig.
2D). This motif exists in the cytoplasmic portions of several
molecules constituting an antigen receptor complex [4^7] and
is involved in the generation of antigen receptor signaling.
TCRj contains three motifs, R contains two, and CD3Q, -N
and -O, IgK, IgL and some Fc receptors contain one. The
motifs have recently been referred to as immunoreceptor
TAM (ITAM), and in this paper ITAM and its variants are
called TAM.
The two motifs of BIT di¡er from the typical motifs. The
former have 20 amino acids between two YxxL/I, while the
latter have 6^8. Longer variant motifs have also been identi-
¢ed in non-antigen receptor molecules, such as mouse and
human homologues of PD-1, a molecule related to the pro-
grammed cell death of immune cells, (19 and 21 amino acids,
respectively) [15,16] and human natural killer cell receptor,
p58/NKAT, associated with MHC class I recognition (26 ami-
no acids) [17,18]. TAMs have only been identi¢ed in mole-
cules in the immune system and in viruses infecting immune
cells [19]. The motifs in BIT were the ¢rst found in the ner-
vous system.
BLAST search reveals that sequences around two tyrosine
residues in each TAM are quite similar to the IRS-1 sequences
around two tyrosine residues that are reported to be binding
sites of two SH2 domains of SHP-2 tyrosine phosphatase
[20,21] (Fig. 2E). We recently demonstrated that TAM of
BIT actually interacts with SHP-2 [8]. Bisphosphotyrosyl pep-
tide corresponding to N-TAM or C-TAM potently stimulates
SHP-2 phosphatase activity (33^35-fold) [8], as a tethered
peptide containing the two IRS-1 phosphorylation sites does
[20,21].
3.4. Tissue distribution of BIT
We examined BIT mRNA expression in several rat tissues
by Northern blotting (Fig. 3A), and a transcript of 4.0 kb was
detected in the brain, a 3.7 kb transcript was found in the
spleen, and faint 3.7 kb transcripts were also detected in the
lung and heart. We previously detected BIT protein only in
the brain among 17 di¡erent tissues by immunoblotting [2,3].
Thus, we re-examined BIT protein expression in various tis-
sues by highly sensitive immunoblotting with polyclonal anti-
body against the puri¢ed BIT (Fig. 3B). In addition to an
intense 90 kDa band in the brain, a faint 130 kDa band
was found in the spleen and a fainter 120 kDa band was
detected in the lung. Immunoblotting with polyclonal anti-
body against a BIT cytoplasmic peptide showed apparently
the same results (data not shown), indicating that the result
shown in Fig. 3B did not strongly re£ect the antibody reac-
tivity to brain-speci¢c modi¢cation, such as glycosylation.
Thus, the 3.7 kb transcripts seem to be translated at very
low levels.
3.5. Tyrosine phosphorylation of BIT in brain suspension
The in vitro tyrosine phosphorylation of BIT was examined
using crude brain suspension. One of the major tyrosine-phos-
phorylated proteins, a molecule of about 90 kDa in the
CHAPS lysate, was immunoprecipitated with anti-BIT anti-
body (Fig. 4), showing that BIT is a major endogenous sub-
strate for protein tyrosine kinase(s) in the brain. This suggests
that BIT plays an important role in signal transduction in the
brain. Phosphorylation appears to cause a structural change,
since phosphorylated BIT migrated more slowly than non-
phosphorylated BIT in SDS gels.
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Fig. 3. Tissue distribution of BIT. A: Northern blot analysis of BIT
mRNA expression. Total RNAs (5.4 Wg) from the indicated tissues
of the adult rat were resolved by electrophoresis through 1% agar-
ose formaldehyde gel, transferred to a nylon membrane and hybri-
dized with the BIT cDNA probe. RNA samples were electrophor-
esed on a separate gel and stained with ethidium bromide to ensure
that quality and quantity of the tissue RNA were equivalent. B: Im-
munoblot analysis of BIT expression. Homogenates (10 Wg protein)
of the indicated tissues of the adult rat were resolved on a 10%
SDS-polyacrylamide gel, transferred to a PVDF membrane and im-
munoblotted with anti-BIT serum.
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3.6. Culture of cerebral cortical neurons on BIT
Some of immunoglobulin superfamily molecules have been
reported to have ability to promote neurite extension [23].
Thus, we examine the e¡ect of BIT as a substrate on primary
cultured neurons. Primary cerebral cortical neurons from E17
rat were cultured on the plates that were coated with BSA,
poly-L-lysine, laminin or BIT (Fig. 5A). BSA could not sup-
port cell attachment and neurite extension. Poly-L-lysine that
is usually used for the primary culture, laminin that is known
as a potent substrate for neurite extension, and BIT could
support cell attachment and neurite extension. Furthermore,
we examined speci¢c involvement of BIT in this e¡ect using
monoclonal anti-BIT antibody that recognize an extracellular
part of BIT [3]. Pretreatment of the BIT-coated plate with this
antibody speci¢cally blocked the neurite extension, but the
pretreatment of the laminin-coated plate showed no e¡ects
(Fig. 5B). These results suggest that BIT on the plate interacts
with the ligand on cerebral cortical cells and this interaction
might support cell attachment and neurite extension.
4. Discussion
BIT is a new type immunoglobulin superfamily molecule
found in the brain. It has three immunoglobulin-like domains
(V, C1, C1) and two TAMs. The overall structure is similar to
those of the immune antigen receptors. Each immunoglobulin
domain of BIT shows high degrees of homology to immuno-
globulin domains of immunoglobulins, TCRs and MHC mol-
ecules (Table 1). Moreover, the immunoglobulin domains of
BIT show high levels of homology to those of primitive im-
munoglobulins (Table 1). BIT probably have evolved from the
same ancestor containing C1-type domain(s) as the antigen
recognition molecules. BIT structurally belongs to a family
that consists of immunoglobulin, TCR and MHC molecule.
However, there are two di¡erences between BIT and the
immune antigen receptors. The ¢rst is that BIT has more
glycosylation sites than the immune antigen receptors. About
30% of the BIT molecular weight calculated using SDS-PAGE
is actually carbohydrate [3]. It is possible that the oligosac-
charide structure of BIT is related to physiological role of
BIT. The second is that the diversity of the V-type domain
of rat BIT has not been found so far.
In the present study we showed that BIT could support cell
attachment and neurite extension of cerebral cortical neurons.
BIT showed no homophilic adhesion activity when transfected
CHO cells expressing BIT at the cell surface were used for the
aggregation assay in the absence and presence of 1 mM Ca
2
and 1 mM Mg
2
(data not shown). These ¢ndings suggest
that BIT may be a heterophilic adhesion molecule, which
interact with a ligand on cerebral cortical cells. Further stud-
ies are required for elucidating the extracellular function of
BIT.
BIT has two longer TAMs. It was reported that molecules
with more TAMs tend to generate more intense signals [22].
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Fig. 5. Culture of cerebral cortical neurons on BIT. A: Cerebral cortical cells prepared from E17 rat were cultured on the plates coated with
BSA, poly-L-lysine, laminin or BIT. Phase contrast micrographs were taken after 45 h culture. B: Pretreatment of the BIT-coated plate with
anti-BIT monoclonal antibody inhibited the neurite extension, but pretreatment of the laminin-coated plate with the same antibody showed no
e¡ects. Control plates were pretreated with control monoclonal antibody (3B12a). Phase contrast micrographs were taken after 24 h culture.
Fig. 4. BIT is one of major endogenous substrates of brain tyrosine kinases in vitro. After incubation of rat brain samples with (+) or without
(3) ATP, proteins were solubilized with 1% CHAPS, and BIT was immunoprecipitated with monoclonal antibody 1D4 attached to Sephar-
ose 4B. The solubilized CHAPS lysates, the unadsorbed supernatants and the immunoprecipitates were immunoblotted with monoclonal anti-
phosphotyrosine (4G10) (left) and anti-BIT (1D4) (right) antibodies. The bands below 80 kDa in the immunoprecipitates were those of the
mouse immunoglobulin chains reacted with a second antibody. IP, immunoprecipitation.
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Thus, strengthening signal is probably the reason why BIT
has two TAMs. The longer TAMs tend to have higher con-
tents of proline between the two YxxL/I sequences; human
PD-1 (5 prolines), p58/NKAT (4 prolines) and BIT (5 and
4 prolines) (Fig. 2D). The long motifs may require proline
residues for functional conformation.
We recently searched for a molecule that interacts with the
tyrosine-phosphorylated BIT in the brain and found that
SHP-2 speci¢cally bound to the phosphorylated BIT through
its SH2 domain in vitro and in living cells [8]. The amino acid
sequences around the tyrosine residues in each TAM are quite
similar to the sequences around the SHP-2 binding sites of
IRS-1 (Fig. 2E). Furthermore, BIT was a major tyrosine-
phosphorylated protein associated with SHP-2 in phosphoryl-
ated rat brain lysate, suggesting that BIT is a major signaling
molecule just upstream of SHP-2 in the brain [8]. In the
present study, we demonstrated that BIT is a major substrate
of protein tyrosine kinases in the brain. These ¢ndings suggest
that BIT is a quite important molecule in signal transduction
in the brain.
We previously reported BIT as a brain-speci¢c protein.
Western blotting of several di¡erent tissues with monoclonal
anti-BIT (1D4) or polyclonal anti-BIT showed that BIT is
speci¢c for the brain [2,3]. However, mRNA of BIT did not
appear to be speci¢c for the brain in the present study. Reg-
ulation at post-transcriptional revel is probably important for
the speci¢c expression of the BIT protein.
The results in the present study and our recent ¢ndings
suggest that BIT functions as a membrane signaling molecule
that might participate in heterophilic cell adhesion. BIT in-
creases postnatally and is highly expressed in the mature brain
[2]. Furthermore, BIT distributes widely and selectively in
synapse-rich regions in the brain, including cerebral cortex
and hippocampus [[2], in preparation]. BIT is also present in
some ¢ber tracts. These ¢ndings suggest that BIT may play a
key role in cell^cell interaction in the neural network and may
be involved in regulation of neuronal function in the mamma-
lian brain. BIT is an immune antigen receptor-like molecule
¢rst found in the nervous system. The structural homology
indicates that BIT may have evolved quite recently through
vertebrate evolution as immune antigen receptors. Thus, it is
quite interesting to consider the possibility that BIT partici-
pates in brain function that have evolved recently through
vertebrate evolution.
Quite recently SHP-2 binding proteins, SHPS-1 and SIRPK,
have been cloned [24,25], and they are the same molecules as
BIT. SIRPK, a human homologue of BIT, has been found as
a family of proteins, and 15 di¡erent sequences of the ¢rst
immunoglobulin-like domain have been reported. This diver-
sity of the V-type immunoglobulin domain of human BIT
(SIRP family) reminds us of its homology to the immune
antigen receptors, and of its possible evolutionary divergence.
We think that it is very important to elucidate the physiolog-
ical role of this quite unique molecule.
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